Koshinski Asset Management Inc. grew its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 17.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,042 shares of the conglomerate’s stock after buying an additional 304 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Danaher were worth $403,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares during the last quarter. Sierra Ocean LLC grew its stake in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after buying an additional 76 shares during the last quarter. Red Tortoise LLC grew its stake in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the first quarter worth about $31,000. Finally, Ramirez Asset Management Inc. bought a new stake in Danaher during the second quarter worth about $40,000. 79.05% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.20% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Check Out Our Latest Analysis on Danaher
Danaher Trading Down 0.5%
Shares of NYSE DHR opened at $208.06 on Tuesday. The company’s 50 day simple moving average is $201.76 and its 200 day simple moving average is $197.42. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $274.21. The firm has a market capitalization of $148.98 billion, a P/E ratio of 44.27, a P/E/G ratio of 2.98 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the business posted $1.72 earnings per share. Danaher’s revenue was up 3.4% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- What is diluted earnings per share (Diluted EPS)?
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- What is MarketRank™? How to Use it
- 3 High-Yield Banks for Investors to Buy on the Dip
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.